CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Planned sale Chief Scientific Officer sold 3,063 shares at $12.04 ($36,879)
- 4 Planned sale See Remarks sold 21,494 shares at $12.04 ($258,788)
- 4 Grant or award Chief Medical Officer acquired 40,363 shares (grant or award)
- 4 Gift See Remarks gave 250,361 shares (gift)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 14,000 shares (grant or award)
- 4 Grant or award Director acquired 14,000 shares (grant or award)
- 4 Grant or award Director acquired 14,000 shares (grant or award)
- 4 Grant or award Director acquired 14,000 shares (grant or award)
- 4 Grant or award Director acquired 14,000 shares (grant or award)
- 4 Grant or award Director acquired 14,000 shares (grant or award)
- 4 Planned sale Chief Medical Officer sold 13,861 shares at $8.05 ($111,581)
- 4 Planned sale Chief Strategy Officer sold 1,862 shares at $7.17 ($13,351)
- 4 Planned sale Chief Development Officer sold 2,974 shares at $7.17 ($21,324)
- 4 Planned sale Chief Scientific Officer sold 3,024 shares at $7.18 ($21,712)
- 4 Planned sale See Remarks sold 21,219 shares at $7.18 ($152,352)
- 4 Open-market buy Director bought 10,000 shares at $6.96 ($69,600)
- 4 Planned sale See Remarks sold 21,475 shares at $6.87 ($147,533)
Page 4 of 18 · 354 filings